Granules buying FDA-approved plants to speed U.S. push; Perrigo recalling infant suspension liquid;

> Granules India is to accelerate its expansion into the U.S. by acquiring Auctus Pharma and its FDA-approved plants. Article

> Perrigo ($PRGO) is recalling 18 batches of its acetaminophen infant suspension liquid because some oral syringes may lack dose markings. Release

> The Bangladeshi government has vowed to continue its crackdown on fake drugs, despite a backlash against its actions. Feature

> Lehigh Valley Technologies is creating 52 jobs as it expands drug production in Pennsylvania. Piece

> Repligen has completed a 9,000-square-foot expansion of its manufacturing facilities in Massachusetts. News (PDF)

> A survey of mid-sized drugmakers found many think it will take up to 5 years to fully implement a serialization program. Article

> Sanofi ($SNY) is planning to upgrade the vaccine plant it runs as a joint venture with the Thai government. Piece